EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CD44 in Group 1 Innate Lymphoid Cells Impacts the Development and Progression of Steatohepatitis

Manon Bourinet, Elodie Vieira, Déborah Rousseau, Stéphanie Bonnafous, Fréderic Soysouvanh, Axelle Strazzulla, Coline Elliot, Stéphanie Patouraux, Pierre S Leclère, Iryna Moskalevska, Julien Cherfils-Vicini, Meri K Tulic und 9 weitere

Liver International · 2025

DOI: 10.1111/liv.70299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Manon Bourinet und 20 weiteren Autor:innen. Beteiligte Einrichtung: Université Côte d'Azur, INSERM U1065, C3M, Nice, France. Hauptthemen laut MEDLINE: Hyaluronan Receptors, Immunity, Innate, Killer Cells, Natural, Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Institut National de la santé et de la Recherche Médicale (INSERM, Université Côte d'Azur, Association Française pour l'Etude du Foie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Innate lymphoid cells (ILCs) play pivotal roles in inflammation and fibrosis, which are key features of chronic liver diseases. The contribution of group 1 ILCs, including natural killer (NK) cells and helper‐like ILC1s, to liver inflammation during steatohepatitis and metabolic dysfunction‐associated steatotic liver diseases (MASLD) is still a matter of debate and requires further investigation.

Methods

We engineered a mouse model of specific deficiency of CD44 in group 1 ILCs and challenged mice with diet‐induced obesity and MASLD or diet‐induced steatohepatitis. We performed in vitro studies and co‐cultured LPS‐stimulated liver NK cells with hepatocytes and macrophages to analyse the inflammatory response.

Results

As group 1 ILCs expressed the cell surface molecule CD44, its specific targeting was used to investigate if CD44 could affect the development of liver inflammation. Here, we found that CD44 deficiency in group 1 ILCs was sufficient to decrease the absolute number of hepatic NKp46 + ILCs, NK cells and ILC1s in chow diet and in response to diet induced‐MASLD or steatohepatitis. CD44 deficiency in group 1 ILCs aggravated liver complications by exacerbating hepatic injury, inflammation, and fibrosis, which was also associated with inflammatory and osteopontin + macrophages accumulation. The absence of CD44 in NK cells enhanced their inflammatory phenotypes in response to LPS, which in turn triggered release of pro‐inflammatory mediators by hepatocytes and macrophages.

Conclusions

Our findings reveal a novel role for CD44 in regulating the dynamics of group 1 ILCs, which in turn affects steatohepatitis and MASLD development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronan ReceptorsImmunity, InnateKiller Cells, NaturalLymphocytesNon-alcoholic Fatty Liver DiseaseFatty LiverAnimalsMiceDisease Models, AnimalDisease ProgressionLiverHepatocytesMaleMacrophagesMice, Inbred C57BLCoculture TechniquesObesity

Stichwörter der Autor:innen

ILC1sMASHMASLDNAFLDNK cellsinflammationsteatohepatitis

Substanzen

Hyaluronan ReceptorsCd44 protein, mouse

Autor:innen und Institutionen

  • Université Côte d'Azur, INSERM U1065, C3M, Nice, France.
  • Université Côte d'Azur, CHU, INSERM U1065, C3M, Nice, France.
  • Université Côte d'Azur, IRCAN, CNRS 7284, Inserm U1081, IHU RESPIRera, Nice, France.
  • Department of Internal Medicine II, Division of Nephrology, University Hospital Regensburg, Regensburg, Germany.
  • Karlsruhe Institute of Technology (KIT), Institute of Biological and Chemical Systems-Functional Molecular Systems (IBCS-FMS), Karlsruhe, Germany.

ORCID-Profile: Carmelo Luci

Förderung

  • Institut National de la santé et de la Recherche Médicale (INSERM
  • Université Côte d'Azur
  • Association Française pour l'Etude du Foie
  • Agence Nationale de la Recherche
  • Deutsche Forschungsgemeinschaft
  • Fondation pour la Recherche Médicale
  • Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche
  • Université Côte d’Azur

Zitieren

APA

Bourinet, M., Vieira, E., Rousseau, D., Bonnafous, S., Soysouvanh, F., Strazzulla, A., Elliot, C., Patouraux, S., Leclère, P. S., Moskalevska, I., Cherfils-Vicini, J., Tulic, M. K., Mack, M., Bailly-Maitre, B., Orian-Rousseau, V., Iannelli, A., Belmer, A., Tran, A., Anty, R., …, & Luci, C. (2025). CD44 in Group 1 Innate Lymphoid Cells Impacts the Development and Progression of Steatohepatitis. Liver International. https://doi.org/10.1111/liv.70299

Vancouver

Bourinet M, Vieira E, Rousseau D, Bonnafous S, Soysouvanh F, Strazzulla A, et al. CD44 in Group 1 Innate Lymphoid Cells Impacts the Development and Progression of Steatohepatitis. Liver International. 2025. doi:10.1111/liv.70299

BibTeX
@article{Bourinet2025,
  author = {Bourinet, Manon and Vieira, Elodie and Rousseau, Déborah and Bonnafous, Stéphanie and Soysouvanh, Fréderic and Strazzulla, Axelle and Elliot, Coline and Patouraux, Stéphanie and Leclère, Pierre S and Moskalevska, Iryna and Cherfils-Vicini, Julien and Tulic, Meri K and Mack, Matthias and Bailly-Maitre, Béatrice and Orian-Rousseau, Véronique and Iannelli, Antonio and Belmer, Arnauld and Tran, Albert and Anty, Rodolphe and Gual, Philippe and Luci, Carmelo},
  title = {CD44 in Group 1 Innate Lymphoid Cells Impacts the Development and Progression of Steatohepatitis},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.70299}
}
Kostenlos starten →